Sanofi US recalls all Auvi-Q epinephrine auto-injectors
Epinephrine injection manufacturer Sanofi US has voluntarily recalled all Auvi-Q (epinephrine injection, USP) products on the market, including 0.15 and 0.3 milligrams strength, because they potentially could deliver an inaccurate dosage. It’s possible that Children’s Hospitals and Clinics of Minnesota patients or families may have received a prescription for this product.
Please contact your health care provider for a replacement prescription. In the event of a life-threatening allergic reaction (anaphylaxis), patients should only use their Auvi-Q device if another epinephrine auto-injector isn’t available, and then call 911.
Go to auvi-q.com for a list of frequently asked questions and more information regarding the recall. Call 1 (877) 319-8963 or 1 (866) 726-6340 from 7 a.m. to 7 p.m. Monday through Friday for information about how to return Auvi-Q devices. Sanofi US will reimburse out-of-pocket costs to those with proof of purchase of epinephrine auto-injectors.
EpiPen Auto-Injector manufacturer Mylan has confirmed it has additional products available for those affected by the Auvi-Q recall.